Raiffeisen Bank International »

Atara Biotherapeutics shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $946 200 4.73

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Atara Biotherapeutics

Adage Capital Partners GP
Redmile Group
Mackenzie Financial
Vanguard Group
Vanguard Capital Management
Point72 Asset Management
Acadian Asset Management
EcoR1 Capital
BlackRock
Geode Capital Management
UBS Group
Staley Capital Advisers
Millennium Management
Jane Street
Vanguard Fiduciary Trust

View all funds holding Atara Biotherapeutics